Pharmacist Salary (2026): PharmD Pay Guide for All 50 States

Licensed pharmacists in the United States earn a national median of $143,489 per year — roughly $68.99/hour. Pharmacist pay sits in the top tier of U.S. healthcare professions, supported by the doctorate-level training requirement, stable demand from health systems and specialty pharmacy, and rising clinical-role utilization in ambulatory care, anticoagulation, oncology, and infectious disease management.

The national median is only the middle of the distribution. Three numbers describe the real range of pharmacist compensation:

• Entry-level pharmacists (10th percentile): $101,107/year — typically newly licensed PharmDs in their first 1–2 years, often in retail community pharmacy at CVS, Walgreens, or independent stores, or as PGY1 residents at hospitals.
• Median pharmacist (50th percentile): $143,489/year — the working RPh with 3–10 years of experience, frequently in retail, hospital staff, mail-order, or long-term care settings.
• Top-earning pharmacists (90th percentile): $177,418/year — senior pharmacists in high-cost metros, BPS-board-certified clinical specialists (BCPS, BCOP, BCACP, BCPP, BCCCP, BCNSP), pharmacy managers and directors, specialty and infusion pharmacy clinical pharmacists, and independent owner-operators.

Geographic location matters, but practice setting and clinical-specialty credential often matter more. Pharmacists in Sunnyvale, CA earn a median of $207,441, while colleagues in Aguadilla, PR earn around $106,820. The decline of retail community pharmacy pay in over-supplied markets, the rise of clinical and ambulatory-care roles in integrated health systems, and the rapid expansion of specialty pharmacy (oral oncology, biologics, gene therapy) all push pay in measurable ways beyond cost of living.

Pharmacist Salary vs PharmD Salary — Are They the Same?

Yes. Pharmacist is the licensed practitioner title; PharmD (Doctor of Pharmacy) is the entry-level professional doctorate, which has been the only U.S. pharmacist credential since the profession's full transition to the doctorate in 2003. Older pharmacists may hold a Bachelor of Science in Pharmacy (BS Pharm), but the license is identical. Every practicing pharmacist in the U.S. has earned a PharmD from a program accredited by the Accreditation Council for Pharmacy Education (ACPE), passed the North American Pharmacist Licensure Examination (NAPLEX) and the Multistate Pharmacy Jurisprudence Examination (MPJE) — both administered by the National Association of Boards of Pharmacy (NABP) — and holds an active state pharmacist license. The credential abbreviation RPh (Registered Pharmacist) is also common. The same job goes by several names in salary surveys and job ads:

• Pharmacist salary / pharmacist pay / RPh salary
• PharmD salary / doctor of pharmacy pay
• Retail pharmacist salary / community pharmacist pay
• Hospital pharmacist salary / inpatient pharmacist pay
• Clinical pharmacist salary / ambulatory care pharmacist pay
• Specialty pharmacist salary / oncology pharmacist pay / infusion pharmacist pay

All of these reference SOC code 29-1051 in the Bureau of Labor Statistics Occupational Employment and Wage Statistics survey — the data source used throughout this site. Pharmacy technicians (CPhT, SOC 29-2052) are tracked under a separate SOC code and earn substantially less; this site reports pharmacist pay only.

Hourly Pay and Practice-Setting Compensation

Retail community pharmacists typically receive an annual salary; hospital staff pharmacists are usually paid hourly, with rotating shift differentials and overtime opportunities. The national median equivalent of $68.99/hour reflects a full-time 40-hour week, but the structure varies sharply by setting:

• Retail chain pharmacists (CVS, Walgreens, Walmart, Kroger, Rite Aid): $115,000–$140,000 base salary in most markets; sign-on bonuses common in shortage geographies, but base pay has been under structural pressure for several years as chains close stores and shift hours.
• Independent and small-chain community pharmacy: pay similar to or slightly below chain retail base, with stronger autonomy and case-mix variety; owner-operators capture upside but bear margin risk.
• Hospital staff pharmacists (decentralized, central, oncology, ED): $115,000–$155,000 annual equivalent; overnight and weekend differentials common; pension or 403(b) match at not-for-profit health systems.
• Clinical and ambulatory care pharmacists (anticoagulation, transitions of care, primary care PharmD): $115,000–$150,000 base; PGY1 residency required for most positions, PGY2 for subspecialty roles.
• Specialty and infusion pharmacy (oral oncology, biologics, gene therapy): $125,000–$170,000+; rapidly growing segment with high clinical-judgment value.
• Managed care, PBM, and industry pharmacists: $125,000–$165,000 base; medical-affairs and medical-information roles in pharma manufacturers higher.
• Federal pharmacists (VA, IHS, DoD, USPHS): stable mid-range pay with strong pension and federal benefits.

Total compensation typically includes ACPE-accredited CE budget, BPS recertification cost, license and DEA fee reimbursement, malpractice coverage, and 401(k) or 403(b) match on top of base pay.

2026 Pharmacist Salary Projection

Pharmacist pay has grown at a compound annual rate of 1.83% over the past five years — slower than other healthcare professions in retail community pharmacy, faster in clinical, specialty, and ambulatory-care settings. Retail base pay has been under pressure from chain closures and pharmacy graduate supply outpacing demand in some markets, while clinical specialty roles have benefited from expanded ambulatory utilization, growth of CMS Medication Therapy Management, and rapid expansion of specialty oral oncology and biologic dispensing. The Bureau of Labor Statistics projects employment for Pharmacists to grow 5% through 2033, with growth concentrated in hospital, specialty, and clinical-ambulatory settings rather than community retail.

A BCOP-credentialed oncology specialty pharmacist at an NCI-designated cancer center can earn nearly 40% more than a retail community pharmacist in the same metro. Four factors explain almost all of the pay gap among today's pharmacists: practice setting, residency and BPS specialty certification, location, and employment model.

1. Practice Setting: The Biggest Pay Driver Today

The single largest pay-shaping decision for a pharmacist today is practice setting. Retail community pharmacy — the largest single employer historically — has seen flat or declining real base pay in over-supplied markets, while hospital, clinical, and specialty pharmacy roles have grown faster than the median:

• Specialty pharmacy and infusion (oral oncology, immunology, hemophilia, gene therapy): the fastest-growing high-pay segment; clinical-judgment intensity and biologics handling expertise support premium pay.
• Hospital clinical and ambulatory care (anticoagulation, transitions of care, ID stewardship, oncology): PGY1 residency typically required, PGY2 for subspecialty; pay strong and rising as health systems integrate pharmacists into care teams.
• Hospital decentralized and central staff: stable mid-range pay with shift differentials and overtime opportunity; 24/7 operations support overnight premiums.
• Managed care, pharmacy benefit managers (PBMs), and industry: non-clinical pharmacist roles in formulary, P&T support, medical affairs, and drug information; pay strong with weekday office hours.
• Retail community (chain and independent): baseline of the pharmacist pay scale today; under structural pressure from chain consolidation and reimbursement compression in most markets.
• Long-term care, mail-order, and remote-verification pharmacy: niche segments with stable mid-range pay and predictable schedules.

2. Residency and BPS Specialty Certification

Entry-level pharmacists start at the 10th percentile — around $101,107 — and typically see meaningful pay growth either through retail-chain step raises or through residency-trained advancement into hospital clinical and specialty roles. The single highest-impact credential is a PGY1 pharmacy residency, increasingly required for hospital and clinical positions, and a PGY2 specialty residency for subspecialty roles. Layered on top, the Board of Pharmacy Specialties (BPS) administers 14 specialty certifications. Holders typically earn $5,000–$20,000 differentials over non-certified peers in the same role:

• BCPS — Board Certified Pharmacotherapy Specialist (the most widely held)
• BCOP — Board Certified Oncology Pharmacist
• BCACP — Board Certified Ambulatory Care Pharmacist
• BCPP — Board Certified Psychiatric Pharmacist
• BCCCP — Board Certified Critical Care Pharmacist
• BCNSP — Board Certified Nutrition Support Pharmacist
• BCIDP — Board Certified Infectious Diseases Pharmacist
• BCGP, BCNP, BCSCP, BCPPS, BCTXP, BCCP, BCEMP — Geriatric, Nuclear, Sterile Compounding, Pediatric, Transplant, Cardiology, Emergency Medicine

Senior PharmDs with 10+ years of experience, residency training, and one or more BPS credentials frequently reach the 90th percentile at $177,418.

3. Location: Geographic Pay Variation

Metropolitan areas with high costs of living offer the highest nominal pharmacist salaries. After adjusting using BEA Regional Price Parities, the real-dollar gap narrows. California, Alaska, Oregon, Washington, and Vermont consistently lead. Specific location-driven factors push pay in measurable ways:

• Pharmacist supply density — markets with multiple pharmacy schools (Boston, Chicago, the Mid-Atlantic) tend to have softer retail base pay because of over-supply; markets with fewer programs (rural Mountain West, Alaska, Hawaii) pay above the national median to recruit.
• Health professional shortage areas (HPSAs) — rural and underserved markets frequently offer $15,000–$50,000 sign-on bonuses, paid relocation, and federal student-loan repayment through the NHSC for clinical-pharmacy roles.
• State scope-of-practice rules — states that recognize pharmacist collaborative practice agreements (CPAs) and provider status expand the value pharmacists deliver and support higher pay.
• Concentration of NCI-designated cancer centers, academic health systems, and specialty pharmacies — markets with dense specialty infrastructure pay above the median for clinical and specialty pharmacists.

4. Employment Model: W2 Staff vs PRN vs Owner vs Industry

W2 hospital and chain-retail pharmacists receive base salary plus benefits, retirement match, license and DEA reimbursement, and CE allowance. PRN and floater pharmacists work shifts on demand at 15–35% above the staff rate, with no benefits. Independent-pharmacy owners — typically experienced PharmDs who acquire or build a community pharmacy — capture full margin above overhead but accept revenue and reimbursement risk; top-quartile owners reach the 90th percentile and above when prescription volume and clinical-service revenue (immunizations, MTM, point-of-care testing) support the cost base. Locum pharmacists work short-term contracts at premium hourly rates for facility coverage gaps. Industry pharmacists at biopharma, PBM, and managed-care employers earn at or above the clinical median with weekday office hours and stock-comp upside.

For a complete city-by-city breakdown of pharmacist salaries — including BLS percentile data (10th, 25th, 50th/median, 75th, 90th), local cost-of-living adjustments, and 2026 salary projections — browse the 1,690+ metro areas tracked in our dataset below.